PTK2B, protein tyrosine kinase 2 beta, 2185

N. diseases: 319; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.050 Biomarker disease BEFREE This study was conducted with aims of investigating how microRNA-212 (miR-212) and the inhibition of aquaporin-9 (AQP9) through the activation of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway plays a role in the prevention of MI. 30017933 2018
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.050 Biomarker disease BEFREE Herein, we sought to correlate eNOS phosphorylation status with cardiomyocyte survival and we investigated the contribution of the proline-rich tyrosine kinase 2 (PYK2)/eNOS axis to the regulation of myocardial infarct size in vivo. 28444132 2017
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.050 Biomarker disease BEFREE Pharmacologic blockade of PYK2 or inhibition of PYK2 activation by Na<sub>2</sub>S reduced myocardial infarct size in mice. 29030392 2017
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.050 AlteredExpression disease BEFREE The knockout MI group had elevated levels of glycogen synthase kinase (GSK) 3β and decreased phosphatidylinositol 3-kinase (PI3K), phosphorylated serine/threonine protein kinase B (p-Akt), and cyclin D1, compared with the wildtype MI group. 28453729 2017
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.050 Biomarker disease BEFREE LRP1 also colocalized with proline-rich tyrosine kinase 2 (pPyk2) and MMP-9 in cardiac fibroblasts in ischaemic areas at 10 and 21 days after MI. 28378397 2017